Key result
DUSP1 overexpression protects against septic cardiomyopathy by restoring FUNDC1-dependent mitophagy and preserving cardiac function.
Why the study?
Dual specificity phosphatase 1 is considered an anti-inflammatory factor, but whether it attenuates inflammation-induced cardiomyopathy by improving mitophagy was unknown.
Does DUSP1 overexpression attenuate lipopolysaccharide-induced septic cardiomyopathy by improving FUNDC1-dependent mitophagy and mitochondrial metabolism in mice and cultured cardiomyocytes?
Does DUSP1 overexpression attenuate lipopolysaccharide-induced septic cardiomyopathy by improving FUNDC1-dependent mitophagy and mitochondrial metabolism in mice and cultured cardiomyocytes?
This preclinical study identifies DUSP1 as a protective anti-inflammatory regulator in septic cardiomyopathy that preserves cardiac function and cardiomyocyte survival by restoring FUNDC1-dependent mitophagy and mitochondrial homeostasis.
Answers are grounded in this paper and cite their sources.
DUSP1 may represent a target in septic cardiomyopathy; hypothesis-generating for FUNDC1 mitophagy but leaves open clinical translation.
OBJECTIVES: Dual specificity phosphatase 1 (DUSP1) is regarded as an anti-inflammatory factor in cardiovascular disorders. Mitophagy removes damaged mitochondria and thus promotes mitochondrial regeneration. We investigated whether DUSP1 could attenuate inflammation-induced cardiomyopathy by improving mitophagy. METHODS: ) mice. RESULTS: Echocardiography revealed that lipopolysaccharide impaired heart function by reducing the cardiac systolic and diastolic capacities of WT mice. Freshly isolated single cardiomyocytes from lipopolysaccharide-treated WT mice also exhibited reduced contractile/relaxation parameters. However, DUSP1 overexpression not only maintained the mechanical properties of cardiomyocytes, but also improved heart performance. Lipopolysaccharide upregulated myocardial inflammatory gene transcription and adhesive factor expression, which increased myocardial neutrophil accumulation and cardiomyocyte apoptosis in WT mice. DUSP1 overexpression inhibited the inflammatory response and therefore promoted cardiomyocyte survival. Lipopolysaccharide disrupted mitochondrial respiration and metabolism in WT cardiomyocytes, but DUSP1 overexpression restored mitochondrial metabolism, maintained the mitochondrial membrane potential and inhibited mitochondrial reactive oxygen species production, possibly by increasing FUN14 domain-containing 1 (FUNDC1)-dependent mitophagy. Silencing of FUNDC1 abolished the protective effects of DUSP1 overexpression on cardiomyocytes and their mitochondria following lipopolysaccharide treatment. CONCLUSION: These results demonstrated that DUSP1 is a novel anti-inflammatory factor that protects against septic cardiomyopathy by improving FUNDC1-induced mitophagy.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2022) studied Lipopolysaccharide-induced septic cardiomyopathy. Dual specificity phosphatase 1 (DUSP1) overexpression (transgenic mice and DUSP1 lentivirus transfection) vs. Wild-type mice and control HL-1 cardiomyocytes treated with lipopolysaccharide was evaluated on Cardiac systolic and diastolic function (LVEF, FS, LVSd, E/A, e'/a', E/e', LVDd) and cardiomyocyte mitochondrial integrity and mitophagy (p=<0.05). DUSP1 overexpression attenuated lipopolysaccharide-induced septic cardiomyopathy, preserved cardiac function, and inhibited cardiomyocyte apoptosis by restoring FUNDC1-dependent mitophagy.
Synapse has enriched 10 related papers. Consider them for comparative context: